Dr. Michael Batty is Bartlett Professor of Planning at University College London (UCL) where he is Chair of the Centre for Advanced Spatial Analysis (CASA). His work is focussed on computer models of cities and their visualisation, and more recently how computation lies at the heart of the smart cities movement. His most recent books are The New Science of Cities (2013) and Inventing Future Cities (2018) published by MIT Press. He is the Editor of Environment and Planning B: Urban Analytics and City Science.

William is a General Partner at SOSV - The Accelerator VC - the #5 most active angel and seed stage investor in the world 2018 with US$700m+ under management. At SOSV he is the Managing Director of Chinaccelerator the only accelerator in Asia to have a unicorn come through its program – Bitmex the #1 crypto exchange by trading volume in the world. He is also Managing Director of MOX - the Mobile Only Accelerator - providing mobile startups with free user acquisition. Previously William was a founding Managing Director at SingTel Innov8 Ventures, a Partner at Softbank China & India Holdings and spent 11 years in equity research most recently with Deutsche Bank where he was top ranked for Internet in Asia and worked on IPOs for Alibaba, Kingsoft and eLong (Expedia).

Ed Boyden is Y. Eva Tan Professor in Neurotechnology at MIT, an investigator of the Howard Hughes Medical Institute and the MIT McGovern Institute, and professor of Brain and Cognitive Sciences, Media Arts and Sciences, and Biological Engineering at MIT. He leads the Synthetic Neurobiology Group, which develops tools for analyzing and repairing complex biological systems such as the brain. Amongst other recognitions, he has received the Canada Gairdner International Award (2018), the Breakthrough Prize in Life Sciences (2016), the NIH Director's Pioneer Award (2013), and is an elected member of the National Academy of Sciences (2019).

Jordan spent over a decade conducting research in Bioengineering and Computer Science with a focus on designing and building patient-oriented bio-instrumentation and measurement equipment, as well as data modeling, interpretation, and visualization. He has completed extensive work in the fields of biostatistics, quantitative data analysis, algorithm development, and signal processing and control. Jordan received a dual B.S. in Mechanical Engineering and Electrical Engineering & Computer Science from the Massachusetts Institute of Technology where he went on to earn his M.S. in Mechanical Engineering. Additionally he completed his Ph.D. in Bioengineering with concentrations in Computational Neuroscience and Biomedical Systems Design from Harvard University while working as an EMT in the Greater Boston Area.

With more than 20 years of experience in standardization, Mary-Luc is now Media Coding and Delivery Standards Manager at Xiaomi, Beijing. Along these years, Mary-Luc participated and contributed to several standards development organizations such as DVB, Pro-MPEG, the video services forum (where he served in the board of directors), SMPTE, ATSC, the DASH Industry Forum, MPEG and 3GPP. Mary-Luc has generated more than 200 contributions to standards in technical areas such as video transport, forward error correction, adaptive streaming, quality of service and virtual reality and has often taken on a leadership role as a contributor, editor and chairman. Mary-Luc is an important contributor to current standardization work in MPEG about future immersive services including point cloud compression and 3GPP SA4 activities on future media codecs. In particular, today, Mary-Luc is co-chair and editor of MPEG-I architectures and MPEG-DASH part 5, co-chair of MPEG-I part 14 on Scene Description and proxy liaison officer between MPEG and 3GPP. 14:21Mary-Luc graduated from the ENSIMAG (the French national computer science and applied mathematics engineering school) in 1997 with a master degree on mathematics and network information systems. He started his career working for VIACCESS Conditional Access system and later joined Technicolor Research & Innovation in France in 1999 where he first started to work on international standardization projects.

Gang Chen is currently Carl Richard Soderberg Professor of Power Engineering at Massachusetts Institute of Technology (MIT). He obtained his doctoral degree from the Mechanical Engineering Department, UC Berkeley, bachelor and master’s degrees from Huazhong University of Science and Technology. He was a faculty member at Duke University and UCLA before joining MIT in 2001. Professor Chen has supervised over 70 graduate students and over 60 post-docs and visiting scholars. About 50 of his former PhD students and post-docs are faculty members around the world. Prof Chen is a fellow of American Physical Society, the American Society of Mechanical Engineers, the American Association for Advancement of Science, and the Guggenheim Foundation. He is a member of the American Academy of Arts and Sciences and the US National Academy of Engineering.

Cheryl Cui is a co-founder and CEO of Bota Biosciences, a synthetic biology company that program and build biological systems to enables clean and efficient bio-manufacturing. Bota aims to build an integrated synthetic biology platform for rapid discovery of products that can serve various industries including industry chemicals, pharmaceuticals, food and agriculture. Cheryl earned her joint PhD degree in Medical Engineering and Medical Physics from MIT and Harvard Medical School. Her research in building synthetic gene circuits and molecular systems have led to publications in Science and Nature journals. In 2019, Cheryl was awarded as one of the US Forbes 30 under 30s in the field of healthcare.

Greg is one of the original tech nomads and has spent his career travelling to and living in every major technology market in the world. He now lives in New Zealand but creates businesses that compete on the international stage. Most recently, PowerbyProxi, a company he co-founded, was sold to Apple in 2017. In 2016, Greg teamed up with Dr. Mark Sagar to create Soul Machines to focus on humanizing Artificial Intelligence and exploring the future of human machine cooperation. With global corporations like Autodesk, Mercedes Benz and Royal Bank of Scotland as early customers, Soul Machines is re-imagining what is possible in the delivery and underlying economics of highly personalized customer experiences and specialized knowledge. Greg is also the Sir John Logan Campbell Executive in Residence at the University of Auckland Business School.

Michael A. Cusumano is the SMR Distinguished Professor and Deputy Dean at the MIT Sloan School of Management. Cusumano specializes in strategy, product development, and entrepreneurship in software, automobiles, and consumer electronics. At MIT, he has recently taught Software & Internet Entrepreneurship as well as Strategy and the CEO. He has published 14 books and more than 120 articles. His latest books are The Business of Platforms: Strategy in the Age of Digital Competition, Innovation, and Power (2019, with A. Gawer and D. Yoffie) and Strategy Rules: Five Timeless Lessons from Bill Gates, Andy Grove, and Steve Jobs (2015, with D. Yoffie, translated into 18 languages).

Prof. Qionghai Dai is an Academician of the Chinese Academy of Engineering, Dean of the School of Information, Tsinghua University, Dean of the Beijing National Research Center for Information Science and Technology, and the Director of the Chinese Association for Artificial Intelligence (CAAI). He was a recipient of the National Science Fund for Distinguished Young Scholars from the National Natural Science Foundation of China (NSFC) in 2005, appointed as a Distinguished Professor of the "Changjiang Scholar Award Program" by the Ministry of Education (MoE) in 2009, and winner of the 2017 National Innovation Competition Award. Prof Dai’s research mainly focus on artificial intelligence (stereovision) and computational photography, and has long been devoted to the theoretical and technological innovation in these fields. He was the principal scientist of several national major grants including The Major State Basic Research Development Program of China (973 program) from Ministry of Science and Technology, Special Fund for Research on National Major Research from the NSFC. He has developed a video rate Real-time Ultra large Scale High resolution macroscope (RUSH), which is expected to advance the progress of brain science and tumor metastasis. He won the second prize of The State Scientific and Technological Progress Award in 2016, the first prize of The State Technological Invention Award in 2012 and the second prize of The State Technological Invention Award in 2008.

To be Updated.

Jennifer has more than 10 years of experience in B2B marketing, public relations, and technology research and development. Before joining AInnovation, she served for SAP for 10 years where she is the head of SAP Greater China industry market and innovative products. Prior to that, she served as market leader and spokesperson for UFIDA, the largest domestic management software manufacturer.

Taylor Guo, Chief Scientific Officer, Ph.D. in Immunology from Shanghai JiaoTong University School of Medicine. Dr. Guo has a decade of discovery and early development experience in neuroimmunology, immuno-oncology and neurodegeneration at I-Mab Biopharma and GSK, with extensive experience in developing facile and robust translatable in vitro and PD assays. He published more than 35 papers.

Dr. Wanqing He is currently the head of Alibaba Cloud High Performance Computing product and a senior technical expert, leading the R&D and business support for Alibaba Cloud's Elastic High Performance Computing and other products. Dr. He has been focusing on HPC since 2005, and has led Intel China HPC engineering team, focusing on parallel application optimization, parallel file system and heterogeneous computing customer support in China and Asia Pacific region, supporting the construction of domestic supercomputing and optimization of a large number of applications such as Numerical weather simulaiton, Oil&Gas meteorology, life sciences, manufacturing simulation and digital content creation, including the development of the Tianhe-2 supercomputing system. He is regarded as distinguished Expert in HPC ecosystem. Dr. He is a member of the Standing Committee of the CCF High Commission, a former Vice President of the CCF YOCSEF and a member of the CCF Council.

Prof. Weizhi Ji currently is Member of Chinese Academy of Sciences, Professor and Director of Institute of Primate Translational Medicine, Kunming University of Science and Technology /Yunnan Key Laboratory of Primate Biomedical Research, President of Chinese Society for Stem Cell Research (2019-2022). Prof. Ji has been engaged in primate reproductive and developmental biology for over 3 decades. His research focuses on mechanism in early embryo development regulation, stem cell pluripotency and nonhuman primate animal models for human diseases. His lab has set up a chain of systems and platforms from in vitro fertilization, early embryonic development, gene editing, stem cell lines that makes his lab a unique and leading institute in nonhuman primate research in the world. His lab reported the first gene-modified rhesus and cynomolgus monkeys via Cas9/RNA-mediated gene targeting in 2014, first proved the feasibility of generate chimeric monkeys using ESCs in 2015 and succeeded in the extended in vitro culture for both monkey and human early embryos in 2019 that gives a rare glimpse into the developmental events of gastrulation in primates and offers insights into the new discoveries of fundamental theories in embryonic development, stem cells and diseases study.

Emotibot was founded in 2015 by Mr. Kenny Chien, the former Partner Director of Engineering at Microsoft, who possesses extensive experience in Conversational AI and Search Technology in multiple languages and led the Xiaoice and Asian Cortanta Product development, a pioneer in new AI chatbot. He is committed to developing technologies and systems on Natural Language Understanding, Automatic Speech Recognition, Computer Vision, and Multimodal Interaction with Emotional Understanding, by which to a build a better life for society and empower enterprises to innovate and develop.

Robert Langer is one of 13 Institute Professors at the Massachusetts Institute of Technology (MIT); being an Institute Professor is the highest honor that can be awarded to a faculty member. He has written over 1,500 articles, which have been cited over 320,000 times; his h-index of 278 is the highest of any engineer in history and tied for the 6th highest of any individual in history (behind Sigmund Freud and a few others). He has more than 1,400 issued and pending patents worldwide. His patents have licensed or sublicensed to over 400 companies. He served as Chairman of the FDA’s Science Board (its highest advisory board) from 1999-2002, and has won over 220 awards.

Zicai Liang was trained as a biologist at Nankai University where he received his B.Sc. and M.Sc. degrees and then as a Molecular Biologist at Uppsala University where he obtained his Ph.D. degree in 1995. He then spent 3 years in Yale University as a postdoc working on Drosophilia molecular genetics. In end of 1998 he moved to Karolinska Institute, Sweden to start his own group working on Genomics technologies as an Assistant Professor. He has also served as director of the Karolinska Institute DNA chip core facility (KICHIP). He also served as a founder and director of several biotech companies in Sweden. In 2004, he was awarded the title of associated professor (docent) at Karolinska Institute. He has alo been a visiting professor at Chinese Human Genome Center North since 2003. He is now a Principal Investigator of the Laboratory of Nucleic Acid Technology at Institute of Molecular Medicine, Peking University (IMM/PKU). He also serves as Chairman of the Education Committee and Vice-Chairman of the Academic Committee of IMM at PKU and Vice-Chairman of Diploma Committee in Biology Science of PKU. In 2010, he was selected Vice Chairman of Nucleic Acid Sub-committee of the Chinese Association of Biochemistry and Molecular Biology. Currently, Prof. Liang’s research interests include application of siRNA and other nucleic acid tools in biomedical research and translational applications among which is in vivo application of siRNA for drug target validation and siRNA drug development.

Jonathan Liu joined BeiGene in 2018 as Senior Vice President, Bio-Manufacturing. He joined BeiGene from Johnson & Johnson (J&J) where he held the position of Head of China Pharmaceutical Development & Manufacturing Sciences (PDMS), responsible for PDMS operations of biologicals, small molecule drugs and vaccine development in the Asia Pacific region. Prior to joining J&J Dr. Liu spent more than 20 years in the industry and has led many drug development projects in CMC, manufacturing, R&D and production facility management, and has contributed to the successful launch, clinical studies and/or other major milestones for ReFacto®，BENEFIX®，FluMist®, ACAM2000® and 20 other drug products for Pfizer, Sanofi, AstraZeneca and Novartis. His ACAM project team completed the entire drug development cycle from discovery to commercialization and national strategic stockpiling in less than five years. In addition, he is a co-author of Quality by Design for Vaccine, a white paper to the U.S. FDA on behalf of the vaccine industry. He has authored or co-authored prolifically, on subjects including the highest volumetric vaccine manufacturing process, and more than 150 scientific book chapters, lectures, journal articles in Nature, Proceedings of the National Academy of Sciences (PNAS) and has more than 20 inventions patented in the U.S., Europe, Japan, Australia and other countries. Dr. Liu holds Ph.D. and DVM degrees from Queen’s University in Canada, and from the Hunan Agricultural University in China, respectively. He completed his post-doctoral fellowship in Harvard Medical School. He has been a member of Advisory Board or board of directors for the United States National Center of Therapeutics Manufacturing, investment firms, biotech companies, various trade organizations and scientific journal review boards.

To be updated.

Dr. Dawei Ma received his PhD in 1989 from Shanghai Institute of Organic Chemistry (SIOC), and did his postdoctoral studies at the University of Pittsburgh and Mayo Clinic. He returned to SIOC in 1994, and was appointed as research professor in 1995. His research interests currently focus on the development of new synthetic methodologies, the total synthesis of complex natural products and their SAR and action mode studies, as well as the discovery of small modulators for target proteins and special biological processes.

Azalia is the co-founder/tech-lead of the Machine Learning for Systems Team in Google Brain where they focus on deep reinforcement learning based approaches to solve problems in computer systems and metalearning. She has a Ph.D. in Electrical and Computer Engineering from Rice University. She has received a number of awards, including the MIT Technology Review 35 under 35 award, the Best Ph.D. Thesis Award at Rice and a Gold Medal in the National Math Olympiad in Iran. Her work has been covered in various media outlets including MIT Technology Review, IEEE Spectrum, and Wired.

Dr. Miguel Nicolelis is the Duke School of Medicine Distinguished Professor of Neuroscience, Professor of Neurobiology, Biomedical Engineering, Psychology and Neuroscience, and founder of Duke's Center for Neuroengineering. He is founder and Scientific Director of the Edmond and Lily Safra International Institute for Neuroscience of Natal; and founder of the Walk Again Project, an international consortium of scientists/engineers, dedicated to developing an exoskeleton device to assist paralyzed patients in regaining their mobility. As a world-renowned leader in understanding the physiological principles that govern mammalian brain circuits, their dynamics and plastic potential in freely behaving animals, Dr. Nicolelis worked to integrate this knowledge with a variety of engineering and computer science tools to create a new paradigm - brain-machine interfaces - which launched the field of neuroengineering. Dr. Nicolelis led the creation of a new generation of neuroprosthetic devices which will likely change the future face of clinical neurology and neurosurgery.

Nancy has served as WaterDrop’s Partner and CTO since August 2020, and is in charge of proprietary technology development and its application in insurance and big health market. Prior to joining WaterDrop, Nancy served as CTO at Uxin Group (NASDAQ: UXIN) from 2014 to 2019, where she participated in the incubation of Uxin Used Car. Nancy set up UXIN's production and research team of nearly a thousand people from scratch, and took the lead in making the transaction and service network of used cars data-based, digitalized and intelligent. Prior to that, Nancy served as a director at 360 Security Technology Inc. (601360.SS), and a manager at Tencent (0700.HK). Nancy received a master’s degree in computer science from School of Software, Peking University.

Mohamad Sawan is Chair Professor in Westlake University, Hangzhou, China, and Emeritus Professor in University of Montreal, Canada. He is founder and director of the Cutting-Edge Net of Biomedical Research And INnovation (CenBRAIN) in Westlake University. He received the Ph.D. degree Université de Sherbrooke, Canada. He is Co-Founder, Associate Editor and was Editor-in-Chief of the IEEE Transactions on Biomedical Circuits and Systems (2016-2019). He is founder of the International IEEE-NEWCAS Conference and of the Polystim Neurotech Laboratory, and Co-Founder of the International IEEE-BioCAS Conference. He was awarded the Canada Research Chair in Smart Medical Devices (2001-2015), and was leading the Microsystems Strategic Alliance of Quebec, Canada (1999-2018). Dr. Sawan published more than 800 peer reviewed papers, two books, 10 book chapters, and 12 patents. He received several awards, among them the Queen Elizabeth II Golden Jubilee Medal, the Shanghai City Mayor Award for International Collaboration, the Qianjiang Friendship Ambassador Award, and the medal of merit from the President of Lebanon. Dr. Sawan is Fellow of the IEEE, Fellow of the Canadian Academy of Engineering, Fellow of the Engineering Institutes of Canada, and “Officer” of the National Order of Quebec.

Professor Shen has been a Full Professor of Computer Science at The University of Adelaide since 2014, and Founding Director of the Machine Learning Theory theme at the Australian Institute for Machine Learning. His research mainly focuses on Machine Learning and Computer Vision. He was recognised as a top 5 researcher for Engineering and Computer Sciences as part of The Australian’s Life time Achievement Leaderboard (Sept. 2020, https://specialreports.theaustralian.com.au/1540291/9/), an exceptional achievement that demonstrates his sustained and exceptional research performance which enhances the research reputation of The University of Adelaide. Professor Shen demonstrates innovative approaches to translate research for economic and societal gain. A recent example is the work he did with a leading mobile phone company on the development of image parsing techniques for AI driven photography – which was successfully deployed to over 30 million mobile phones in 2018. His student alumni include two Australian Research Council DECRA fellows and additional graduates who are now in tenured or tenure track roles in Universities including the University of Adelaide, Sydney University, Monash University, Wollongong University, Nanyang Technological University Singapore, and a few other universities in China. Besides, 3 of Prof. Shen’s PhD students won the prestigious Google PhD Fellowships.

Yichen Shen is a co-founder and CEO of Lightelligence. He received his PhD degree in Physics from MIT in 2016, where his research focused on nanophotonics and artificial intelligence. Through his PhD, Yichen has published more than 25 peer-reviewed journal papers and has filed 10 US patents, including first authored papers in Science, Nature Photonics, and ICML (the top machine learning conference). In 2017, Yichen received Forbes 30 under 30 Global and MIT Technology Review 35 Innovators under 35 (TR35) China.

To be Updated.

Fiona Tan drives the continued growth of Wayfair’s world-class Engineering organization while setting the vision and strategy for the development of systems and technologies that shape customer and supplier experiences. Prior to Wayfair, Fiona served as senior vice president of U.S. Technology at Walmart where she was responsible for innovation and engineering execution spanning its site, mobile app and all associate and merchant-facing technology across its e-commerce and stores business in the U.S. Her prior roles at Walmart include senior vice president of Customer Technology and vice president of Engineering. Prior to Walmart, Fiona served in a number of leadership roles at Ariba, where she led a global engineering organization responsible for the strategy, lifecycle, and delivery of the Ariba Commerce Network, as well as TIBCO Software. Fiona has a master’s degree in Computer Science from Stanford and a bachelor’s degree in Computer Science and Engineering from MIT.

Dr. Matthew Wang holds PH.D in Computer Science from Vanderbilt University and MBA degree from George Washington University. In 1998, Dr. Wang joined IBM as the Chief Architect of IBM's global supply chain for personal computer . He has also served as Director of IBM Global Service Department, Assistant President of Global R&D Center, Director of Silicon Valley Development Center, General Manager of Sales at Asia Pacific Headquarters. In 2008, he became the Global Vice President of IBM, responsible for the development of strategic platforms such as big data, artificial intelligence and cloud computing. In 2016, Dr. Wang joined Cybernaut as President of Cybernaut Investment Group and Chairman of Cybernaut International. In 2020, Dr. Wang joined We-Doctor as CTO of We-Doctor Group and CEO of We-Doctor Cloud, leading the construction and operation of We-Doctor technology and We-Doctor international platform. In China, Dr. Wang is Vice Chairman of Center for China and Globalization (CCG), Vice Director of China National Big Data Expert Committee, Vice Director of China National Cloud Computing Expert Committee, Director of the European and American Alumni Association, Director of China Enterprise Confederation, Executive Dean of Zhejiang University Innovation Institute International, Professor of Practice for ZJU-SMU DBA , Visiting Professor of Zhejiang University ,Tsinghua University, China Europe International Business School and Cheung Kong Graduate School of Business.

Dr. Zhong Lin Wang is the Hightower Chair in Materials Science and Engineering and Regents’ Professor at Georgia Tech, and founding director and chief scientist of the Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences. Prof. Wang’s discovery and breakthroughs in developing nanogenerators establish the principle and technological road map for harvesting mechanical energy from environment and biological systems for powering a personal electronics. His research on self-powered nanosystems has inspired the worldwide effort in academia and industry for studying energy for micro-nano-systems. He coined and pioneered the field of piezotronics and piezo-phototronics. From SCI database, Wang’s entire publications have been cited for over 135,000 times with an h-index of 180, ranking No. 1 in Google Scholar public profiles in Nanotechnology and Nanoscience in total citations and h-index impacts.

Dr. Xia Dongkun, vice president of Galactic Energy Aerospace Technology CO., LTD, had worked in China Academy of Launch Vehicle Technolog and CASC. More than 10 years experience of aerospace model research and strategic planning management. Dr. Xia Dongkun owns enterprise management innovation award for national defense science and technology industry, advanced individual award of CASC , technical improvement and rationalization recommendation award of China academy of launch vehicle technology, in addition, Hsia owns more than 10 national invention patents.

To be updated.

Wayne Shiong is a Partner at China Growth Capital, a Beijing-based early stage technology investor since 2006. Wayne leads frontier technologies sector at the firm with investments like WeRide (a.k.a JingChi), DeePhi (sold to NASDAQ: XLNX), Mech Mind, HealthBio, Sobot, Landscape Aerospace etc. He was a Partner at Bertelsmann Asia Investments (BAI) with led investments like iClick (NASDAQ: ICLK), Mogujie (NYSE: MOGU), Douban and domob (sold to BlueFocus SZSE 300058) etc. Prior to BAI, Wayne was a Partner with WI Harper Group, a cross border early stage investor in technology and healthcare where he worked on Maxthon, Go Mobile (NASDAQ: GOMO), Mapbar (sold to NASDAQ: RENN), ChIVD (sold to Actis), Edan Instrument (Shenzhen Stock Exchange: 300206) and Innovation Works. Wayne started his investment career as Consultant to Piper Jaffray's Internet equity research team. Prior to Piper Jaffray, he was a co-founder of a Bluetooth start-up funded by Mobile Internet (Asia). Wayne grew up in Beijing with a B.A. in Economics from Peking University. China Growth Capital is a Beijing-based early stage technology investor since 2006, managing $1B to back companies from seed stage to early growth. Notable portfolio companies include SMZDM, Wish, Miss Fresh, 2Dfire, RippleLabs, PingCAP, WeRide, Tongdun etc.

Dr. Pengfei Yuan has nearly ten years of experience in gene editing technology development and application transformation. He is currently the Chief Technology Officer at EdiGene. Dr. Yuan is part of the earliest group of Chinese scholars exposed to genome editing technologies. He has made many valuable contributions to improve and develop genome editing technologies. His research results have been published in Nature, Cell, Nature Biotechnology and other top science publications. Dr. Yuan was also the former executive director of many key projects funded by the National Natural Science Foundation of China. His personal honors include being selected as Beijing Science and Technology New Star, Zhongguancun Young Eagle Talent, and winning the first prize of Beijing Youth Excellent Science and Technology Paper.Dr. Yuan holds a double bachelor's degree and doctorate degree from Peking University. During his PhD and postdoctoral studies, he studied under Professor Wei Wensheng, a well-known expert in the gene editing field. He also has the title of Associate Researcher in the Beijing Natural Science Research Series.

Gleb Yushin is a Co-Founder & CTO of Sila Nanotechnologies. He is also a Professor of Materials Science at Georgia Institute of Technology and an Editor-in-Chief for Materials Today. Gleb has co-authored over 150 peer-reviewed publications and over 40 patents. For his contributions to the development of energy storage materials, Gleb has received numerous awards and was recognized as one of the world’s most influential scientific minds by the Electrochemical Society. Gleb holds BS and MS degrees in Physics from Polytechnic Institute and a Ph.D. in Materials Science from North Carolina State University.

To be updated.

Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine (insilico.com), a leader in next-generation artificial intelligence technologies for drug discovery and biomarker development. Under his leadership Insilico raised over $52 million in multiple rounds from expert investors, opened R&D centers in 6 countries and regions, and partnered with multiple pharmaceutical companies achieving millions in immediate revenue and over a billion in potential future milestones and royalties. He is also the founder of Deep Longevity, a company applying deep learning technologies for prediction of human biological age using multiple data types. Since 2015 he invented critical technologies in the field of generative adversarial networks (GANs) and reinforcement learning (RL) for generation of the novel molecular structures with the desired properties and generation of synthetic patient data. Since 2012 he published over 130 peer-reviewed research papers, and 2 books. He is the adjunct professor of artificial intelligence at the Buck Institute for Research on Aging.